Genesis Techsp. z o.o. in liquidation
Research and experimental development on biotechnology
KRS: NIP: REGON:
Overview
Status
Suspended
Registry date
2015-06-12
Share capital
5,000.00 PLN
Registered address
ul. Eljasza Walerego Radzikowskiego 17/4, 31-315 Kraków, Poland
Electronic delivery address
AE:PL-27888-50379-EABBE-28
Financials
Only balance sheet data (assets and liabilities) is available. The income statement (P&L) is not available in the source filing for this period.
Revenue history
Filing timeliness
No financial statement for 2025 – the filing deadline has passed. 5 of 6 financial statements were filed late (the longest delay 650 days for 2019).
- 2025not filed
- 202423/01/2026
- 202314/06/2024
- 202214/06/2024
- 202127/07/2022
- 202027/07/2022
Filed on timeDelayFiling deadline
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Industry
Authorized Representatives
Rafał Maciej Olszowski – Liquidator
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
| 50 | $675.31 | 50% | |
Jerzy Szymczykage 77 | 50 | $675.31 | 50% |
Beneficial owners
No beneficial owners recorded for the company Genesis Tech.
Bank accounts
Was a VAT taxpayer from 2015-07-01 to 2026-07-02.
Reason for removal: Art. 96 ust. 9a pkt 1 (business activity suspended for at least 6 consecutive months)
Debt
No entries in the National Debtors Register (KRZ).
MSiG notices
| Publication date | Event | |
|---|---|---|
| Nov 12, 2019 | Liquidation opened |
Public aid
No public aid cases recorded in the last 10 years.
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| MedappS.A. | $3,351,163.61 | medapp.pl | ||
| EIT Rawmaterials Clc Eastsp. z o.o. | $1,795,803.10 | eitrawmaterials.eu | ||
| COS LabP.S.A. | $1,028,123.83 | coslab.pl | ||
| IntelliseqS.A. | $111,419.60 | intelliseq.pl | ||
| Przedsiębiorstwo Wielobranżowe Genezasp. z o.o. | $54,163.54 | geneza.eu | ||
| Medtransfersp. z o.o. | $21,666.01 | codete.com | ||
| Oncotherics PolandS.A. | $7,565.33 | oncotherics.com | ||
| Fusiomicasp. z o.o. | $5,263.98 | fusiomica.com | ||
| Ncage TherapeuticsS.A. | $29.14 | ncage.org | ||
| SelvitaS.A. | – | selvita.com |
Change history
| Date | Event | |
|---|---|---|
| 2025-09-16 | Business suspended | |
| 2025-05-13 | Business resumed | |
| 2019-11-21 | Name change (Genesis Tech → Genesis Tech Spółka Z Ograniczoną Odpowiedzialnością W Likwidacji) | |
| 2019-10-10 | Liquidation opened | |
| 2016-12-01 | Business suspended |
FAQ
The main business activity of Genesis Tech focuses on research and experimental development on biotechnology.
The company was registered in the Polish National Court Register (KRS) on June 12, 2015.
The headquarters is located at: ul. Eljasza Walerego Radzikowskiego 17, 31-315 Kraków.
The share capital of the company is PLN 5,000 (approx. $1,351).
The latest available financial statement covers the period from January 1, 2024 to December 31, 2024.
Last updated: 2026-04-12